HUDSON, N.Y., May 30, 2017 -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it has signed a license agreement with ERS Genomics (“ERS”) to utilize the company’s CRISPR-Cas9 technology to generate unique murine models.
Under the agreement, Taconic receives a worldwide non-exclusive license to the CRISPR-Cas9 patents often referred to as the “UC Berkeley patent.” ERS Genomics founder, Emmanuelle Charpentier, is a co-inventor of the CRISPR-Cas9 technology. This agreement with ERS complements Taconic’s CRISPR service platform, adding to its existing license with the Broad Institute. Holding licenses with both groups provides Taconic access for use in all cell types as well as for use in both mouse and rat species, a rare distinction within the animal model field.
“There is no doubt that CRISPR-Cas9 has revolutionized gene editing and thus drug discovery. Adding the ERS technology to Taconic’s existing CRISPR platform allows the company to stand out among competitors by offering a fully-licensed, comprehensive CRISPR platform,” shared Dr. John Couse, Taconic Biosciences’ director of genetically modified model design.
“We are very pleased to add Taconic to our list of licensees as it furthers our goal of making this technology more broadly accessible and Taconic is certainly a globally recognized leader in the animal model field,” added Eric Rhodes, chief executive officer of ERS.
Taconic is a fully-licensed provider of rodent model generation services and has twenty years of model design experience. The company provides gene inactivation, gene mutation or replacement, transgene expression, RNAi, and gene editing via CRISPR-Cas9, pronuclear injection, and homologous recombination technologies to ensure that the right tools are leveraged for each specific customer project. Taconic’s unique capability of providing a seamless transition from model design to breeding and colony management, offers customers a complete solution. These scientific services include acquiring or generating, importing, licensing, breeding, testing, preparing, and distributing genetically engineered models to any location worldwide.
To learn more about Taconic's custom model generation, please call 1-888-TACONIC (888-822-6642) in the US, or +45 70 23 04 05 in Europe, or email [email protected].
About Taconic Biosciences, Inc.
Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic helps biotechnology companies and institutions acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.
Media Contact: Kelly Owen Grover Director of Marketing Communications (518) 697-3824 [email protected]


Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War
Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook
OpenAI Reportedly Eyes Late-2026 IPO Amid Rising Competition and Massive Funding Needs
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment
Saks Global to End Saks on Amazon Partnership Amid Bankruptcy Restructuring
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race 



